Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.36 |
| ▸ | FNTB | P49356 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3847687 | 1.00 | FNTA (0.36) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| Hydrogen Sulfide SCHEMBL8505278 | 0.98 | FNTA (0.35) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL22554340 | 0.85 | — | — | |
| SCHEMBL3847692 | 0.84 | FNTA (0.41) | FNTAFNTBTHRBPGGT1BALDH1A1 | |
| SCHEMBL7185104 | 0.84 | FNTA (0.41) | FNTAFNTBTHRBPGGT1BALDH1A1 | |
| SCHEMBL2175544 | 0.83 | ALOX15 (0.31) | ALDH1A1CES2CES1 | |
| SCHEMBL886924 | 0.82 | FNTA (0.37) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL290897 | 0.82 | FNTA (0.37) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL5086044 | 0.81 | FNTA (0.36) | FNTAFNTBTHRBPGGT1BFFAR3 | |
| SCHEMBL5086033 | 0.81 | FNTA (0.36) | FNTAFNTBTHRBPGGT1BFFAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773905-B1 | HYDROXYL-TERMINATED THIOCARBONATE CONTAINING COMPOUNDS, POLYMERS, AND COPOLYMERS, AND POLYURETHANES AND URETHANE ACRYLICS MADE THEREFROM | LUBRIZOL ADVANCED MAT INC (US) | 2013-10-09 | — | — | EP | claimed |
| CN-116848466-A | Positive photosensitive resin composition | 日产化学株式会社 | 2023-10-03 | — | — | CN | disclosed |
| CN-113214586-B | Glasses lens material for resisting blue light, glasses lens and preparation method thereof | 天辰创新材料科技股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| US-10835474-B2 | Agent and method for the temporary shaping of keratinous fibers | HENKEL AG & CO. KGAA (DE) | 2020-11-17 | — | — | US | disclosed |
| WO-2020184420-A1 | RESIN COMPOSITION, RESIN FILM AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2020-09-17 | — | — | WO | disclosed |
| WO-2020184424-A1 | LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2020-09-17 | — | — | WO | disclosed |
| US-10668004-B2 | Agent and method for the temporary deformation of keratinous fibers | HENKEL AG & CO. KGAA (DE) | 2020-06-02 | — | — | US | disclosed |
| US-20180168989-A1 | AGENT AND METHOD FOR THE TEMPORARY SHAPING OF KERATINOUS FIBERS | HENKEL AG & CO. KGAA (DE) | 2018-06-21 | — | — | US | disclosed |
| US-20180168990-A1 | AGENT AND METHOD FOR THE TEMPORARY DEFORMATION OF KERATINOUS FIBERS | HENKEL AG & CO. KGAA (DE) | 2018-06-21 | — | — | US | disclosed |
| US-20180168988-A1 | AGENT AND METHOD FOR TEMPORARY DEFORMATION OF KERATINOUS FIBERS | HENKEL AG & CO. KGAA (DE) | 2018-06-21 | — | — | US | disclosed |
| EP-2427278-B1 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M INNOVATIVE PROPERTIES CO (US) | 2015-09-23 | — | — | EP | disclosed |
| US-8616201-B2 | Medicinal inhalation devices and components thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2013-12-31 | — | — | US | disclosed |
| US-20120097159-A1 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY | 2012-04-26 | — | — | US | disclosed |
| EP-2427278-A1 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M Innovative Properties Company (US) | 2012-03-14 | — | — | EP | disclosed |
| WO-2010129758-A1 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2010-11-11 | — | — | WO | disclosed |
| US-20100263667-A1 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY | 2010-10-21 | — | — | US | disclosed |
| EP-2205301-A2 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M Innovative Properties Company (US) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009061902-A2 | MEDICINAL INHALATION DEVICES AND COMPONENTS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2009-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180168990-A1 | AGENT AND METHOD FOR THE TEMPORARY DEFORMATION OF KERATINOUS FIBERS | KRT18, DSG1, DSP | FNTA 4094/4885FNTB 3399/4885THRB 3708/4885 |
| US-10668004-B2 | Agent and method for the temporary deformation of keratinous fibers | KRT18, DSG1, DSP | FNTA 4094/4885FNTB 3399/4885THRB 3708/4885 |
| US-20180168988-A1 | AGENT AND METHOD FOR TEMPORARY DEFORMATION OF KERATINOUS FIBERS | KRT18, DSG1, DSP | FNTA 4077/4885FNTB 3461/4885THRB 3578/4885 |
| US-10835474-B2 | Agent and method for the temporary shaping of keratinous fibers | KRT18, DSG1, CKAP4 | FNTA 4332/4885FNTB 3547/4885THRB 3492/4885 |
| US-20180168989-A1 | AGENT AND METHOD FOR THE TEMPORARY SHAPING OF KERATINOUS FIBERS | KRT18, DSG1, CKAP4 | FNTA 4332/4885FNTB 3547/4885THRB 3492/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.